Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

Something exceptional happened at last week’s ACCC 34th National Oncology Conference. No, not the exceptional conference attendance of nearly 800 multidisciplinary oncology professionals for a “how to” focus on cancer care delivery. No, not the exceptional sessions with practical “how to’s” for improving processes, patient satisfaction, quality reporting, data collection, and workflow. And no, not …
October is Breast Cancer Awareness month. In this guest blog post, breast cancer survivor Meredith Goldberg shares her perspective on the importance of making space to “just breathe.” There was a moment when the voice on the other end of the line told me, “I’m sorry to tell you this, but you have cancer,” that I thought for sure that I was part of a very elaborate prank. Breast cancer? Me? I’m only …
The treatment of non-small cell lung cancer (NSCLC) has rapidly evolved over the last several years as new molecularly targeted therapies have been approved by the U.S. Food and Drug Administration (FDA). Among these therapies are novel drugs that target EGFR, ALK, and ROS1 mutations in patients with NSCLC. Anticipating that advances in lung cancer care will be driven by molecularly-targeted …
After nearly seven years as a quality leader in the outpatient oncology setting, I still remember my first days as a newcomer to ambulatory cancer care. I had many years of experience in large acute care hospitals, where quality roles are fairly well defined and quality priorities are well known: Risk, mortality, readmissions, cost, regulatory needs, and data-driven metrics are the norm. However, …
Rockville, Md.—This “how-to” conference for the multidisciplinary oncology care team delivers effective practices for improving program operations, resolving gaps in care delivery, tackling industry challenges, and enhancing the patient experience. What: Association of Community Cancer Centers 34th National Oncology Conference When: October 18-20, 2017 Where: Music City Center, Nashville, Tennessee …
No matter the cancer site or type of treatment, negative outcomes are disproportionately prevalent in underserved communities. For instance, a recent report finds that in the Appalachian Region, cancer mortality rates are 10 percent higher than the national rate, and the cancer mortality rate in that region is 15 percent higher in rural counties than in metro counties.1 To combat cancer disparities …
On August 30, the U.S. Food and Drug Administration (FDA) approved the first CAR Chimeric Antigen Receptor (CAR) T-cell therapy, tisagenlecleucel (Kymriah). With this approval of the first cancer gene therapy in the U.S., immuno-oncology took a historic step forward. Later that same day, in a press release titled, “Innovative Treatments Call for Innovative Payment Models and Arrangement,” the Centers …
The development and use of oral agents in treatment for oncology and blood disorders has exploded over the last decade and half. Today, these agents bring many benefits to patients and cancer care staff, but along with those benefits come challenges. Then . . . and Now Thinking back to 2001, for example, when capecitabine, the first oral chemotherapy for the treatment of metastatic colorectal cancer …
On August 21, 2017, ACCC submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding the agency’s proposed 2018 updates to the Quality Payment Program (QPP), a two-track value-based reimbursement system created by the Medicare Access and CHIP Reauthorization Act (MACRA). The two tracks in which eligible clinicians can opt to participate are the enhanced fee-for-service based …
Eliminating barriers to care in rural health communities is paramount to improving social work practice in cancer care delivery. The Providence St. Joseph Health Cancer Program utilized student volunteers to deliver a higher quality of care.
Currently, nearly 2.3 million U.S. inmates (about 1 percent of U.S. adults) must rely on their jailers for healthcare. However, there is little nationally available data on the health and healthcare of America’s prisoners.
The ACCC education project, “Virtual Molecular Tumor Boards,” examines how innovative formats can help ensure that communication and quality patient care standards are maintained across cancer programs.
Sometimes referred to as the “terminator,” glioblastoma (GBM) is one of the deadliest forms of brain cancer.
As I look back and reflect on the process of creating the James M. Stockman Cancer Institute, there are several lessons learned on the journey that could benefit any cancer program.
ASCO 2017 was filled with new information and long lines as 39,000 oncologists worldwide came together to hear the latest advances in cancer care.
SO17-final
While the 340B Program has grown, and reform has been widely debated by policymakers over the past decade, CMS’ rule proposes to fundamentally alter the program (notably a program that is not within CMS’ purview).
Nearly 13 years ago, I slipped through a significant and potentially fatal crack in our healthcare system when I was diagnosed with advanced stage breast cancer.
In 2009 Georgetown Community Hospital partnered with nearby University of Kentucky Markey Cancer Center to establish a cancer program that serves Scott County and neighboring areas of the Bluegrass State, providing close-to-home cancer care to a larger population.
The Foundation for Hospital Art (FFHA) has created more than 44,000 paintings for more than 4,000 hospitals in 195 countries over the last 30+ years.